RCM
LMAT icon

Raleigh Capital Management’s LeMaitre Vascular LMAT Stock Holding History

Raleigh Capital Management’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19
Closed -$2.07K – 691
2026
Q1 		$2.07K Buy
+19
New +$1.81K ﹤0.01% 524

Other funds holding LMAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Raleigh Capital Management's LMAT Position: Q2 2026 in Review

Raleigh Capital Management sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 19 shares — an estimated $2.07K sold.

Raleigh Capital Management first reported a position in LMAT in Q1 2026 and held it in 1 quarter. The position peaked at $2.07K in Q1 2026. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Raleigh Capital Management reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
  • Raleigh Capital Management sold 19 LeMaitre Vascular shares in Q2 2026, an estimated $2.07K.
  • Raleigh Capital Management first reported a position in LeMaitre Vascular in Q1 2026 and held it in 1 quarter.
  • Raleigh Capital Management's LeMaitre Vascular position peaked at $2.07K in Q1 2026.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Raleigh Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.